Purchase Order HT001425PE012
- Not listed
- The federal contract award HT940623P0100, valued at $91,029.00, was issued by the Defense Health Agency (DHA) to Haemonetics Corporation, a leading medical technology company, for the provision of implementation services. This is a firm-fixed-price purchase order contract with no set-aside designation, indicating Haemonetics' competitiveness as a large, established provider of specialized medical equipment and services to government healthcare agencies. The contract includes the supply of...
- The Defense Health Agency, a component of the Department of Defense, awarded a $24,028 purchase order to Haemonetics Corporation for the delivery of 325ml of DE-GLYCE. Performance will take place in Bethesda, Maryland under firm fixed pricing. As a leading provider of blood and plasma collection, processing and delivery technologies, Haemonetics will supply the contracted medical device and consumables to support the Agency's health care programs. No subcontractors or set aside designations were...
- This $67,003.20 firm-fixed price purchase order was awarded by the Bureau of Medicine and Surgery, a component of the Department of Defense, to Haemonetics Corporation, a leading provider of blood and plasma management products and services. The contract does not have a set-aside designation. The award is for the delivery of 0236-00 items as described in the contract, likely blood processing equipment and consumables. Haemonetics is an established medical device manufacturer that has received...
- This is a $17,070,912.72 Firm Fixed Price Delivery Order awarded by the Defense Health Agency to 5D Information Management, Inc., a subsidiary of Haemonetics Corporation. The contract is for the provision of labor and has a completion date of December 19, 2023. The contract does not have a set-aside designation. Haemonetics is a provider of blood and plasma supplies and services, including devices and consumables for blood collection, processing, and management. The company has a history of...
- This is a firm-fixed price purchase order awarded by the Defense Health Agency (DHA) to Haemonetics Corporation, a leading provider of blood and plasma supplies and services, for $30,688.30. The contract is for blood consumable supplies such as blood bags, tubing sets, reagents, and solutions. The award has an ultimate completion date of August 1, 2022 and does not utilize a set-aside. Haemonetics is the prime contractor and no subcontractors are identified. The DHA, which delivers integrated...
- The Defense Health Agency has awarded a $48,040.35 firm-fixed price purchase order to Haemonetics Corporation for the delivery of a venous vascular closure system to the Walter Reed National Military Medical Center. This award has no set-aside designation and is for medical equipment and supplies to support the agency's mission of providing healthcare to military personnel. Haemonetics is a leading provider of innovative blood and plasma management solutions, including specialized devices and...
- This firm-fixed price purchase order was awarded by the Defense Health Agency to Haemonetics Corporation, a leading medical technology company specializing in blood and plasma management products and services. The $76,690.80 contract is for the delivery of DEGLYCEROLIZATION KIT LARGE, with a performance period ending on January 1, 2016. Haemonetics is an established supplier of specialized medical equipment to various government healthcare systems, including the Department of Veterans Affairs...
- This federal contract award, valued at $48,018.40, was issued by the Defense Health Agency (DHA) to Haemonetics Corporation, a leading provider of blood and plasma management products and services to the U.S. government. The contract is for the delivery of arterial and venous closure sheaths, which are medical devices used in surgical and clinical settings. The contract does not have a set-aside designation, indicating that Haemonetics was selected as the prime contractor on an...
- This is a firm-fixed price purchase order awarded by the Defense Health Agency (DHA) to Haemonetics Corporation, a leading medical technology company, for the delivery of Lab Analyzers. The contract has a ceiling value of $71,916.00 and an ultimate completion date of October 31, 2024. There is no set-aside designation, indicating Haemonetics competed effectively as a large, established supplier. The contract is part of Haemonetics' broader portfolio of medical device and equipment supply...
- The federal contract HT001416P0025 was awarded to Haemonetics Corporation, a leading provider of blood and plasma management products and services to the U.S. government. The $14,700.00 firm-fixed price purchase order, issued by the Defense Health Agency, is for the maintenance and service of ACP (automated cell processors). The contract has no set-aside designation. The contract award is associated with a larger indefinite delivery vehicle (IDV) Haemonetics holds with the Department of Veterans...
The Defense Health Agency awarded a $39,282.35 firm fixed-price purchase order to Haemonetics Corporation for hemostasis supplies. The award, issued on August 8, 2025, with an ultimate completion date of August 8, 2025, represents a straightforward procurement with no set-aside designation, indicating open and competitive bidding. Performance will take place in Bethesda, Maryland. Haemonetics, a Boston-based medical technology leader, specializes in blood and plasma management products and is well-established in federal healthcare contracting, having maintained SAM.gov registration since 2002. The Defense Health Agency, responsible for providing healthcare services to military beneficiaries, regularly procures hemostasis and blood management solutions from qualified vendors. Haemonetics' comprehensive product portfolio—including hemostasis analyzers, blood recovery systems, vascular closure devices, and related consumables—aligns with the Agency's medical supply requirements. This purchase order reflects the company's established relationship with the Defense Health Agency, supported by broader federal contracting experience across the Department of Veterans Affairs, National Institutes of Health, and other healthcare agencies. Haemonetics maintains significant federal contracting volume, including a substantial $3.8 million indefinite delivery contract with the Department of Veterans Affairs for autotransfusion equipment and related supplies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $39.3k | 8/7/25 |